Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-288-5 | CAS number: 93-92-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Short description of key information on bioaccumulation potential result:
The toxicokinetics of the substance were assessed by literature available on benzyl acetate, a structurally similar substance to 1-phenylethyl acetate, which is expected to follow the same metabolic pathway as the test substance. The available data indicated that initially, the substance undergoes rapid hydrolysis in the body and undergoes several enzyme dependent steps to eventually form hippuric acid. Several investigations within two of the three studies demonstrated that the metabolic pathway (the CoA conjugation pathway) can become saturated, affecting the rate and quantity at which metabolites are formed and also the dependence on the availability of glycine (this was not demonstrated in the NTP (1986) study). Excretion of benzyl acetate was found to be rapid, and was complete by 72 hours with negligible amounts retained in the body.
Short description of key information on absorption rate:
Low level absorption of the benzyl acetate occurs through human skin in vitro. Human skin in less permeable to benzyl acetate than rat skin. The information available indicates that some low level systemic exposure to the test substance will occur, however testing dermally in animal models is likely to overestimate systemic exposure.
Key value for chemical safety assessment
- Bioaccumulation potential:
- low bioaccumulation potential
- Absorption rate - oral (%):
- 50
- Absorption rate - dermal (%):
- 17.8
- Absorption rate - inhalation (%):
- 100
Additional information
Toxicokinetics
Three studies were submitted as a weight of evidence to address the toxicokinetics of 1-phenylethyl acetate, both of which were performed on benzyl acetate. Benzyl acetate is structurally very similar to 1-phenylethyl acetate and is expected to follow the same metabolic pathway.
The focus of Yuan et al (1995), was to provide a rudimentary map of the metabolic pathway of benzyl acetate using both in vivo and in vitro techniques and to determine whether the route (oral gavage vs. oral feed) influenced the rate of metabolism. The study was reported to a high standard, and performed in line with good scientific principles, as such a reliability score of 2 was considered suitable, in accordance with Klimisch (1997). From the in vivo and in vitro tests, benzyl acetate and benzyl alcohol were found to undergo rapid hydrolysis in the blood to form benzoic acid. The proposed metabolic pathway model of benzoic acid was a first-order input and a first order elimination mechanism for hippuric acid. The elimination rate of benzoic acid was found to be greater than the formation rate hippuric acid. Hippuric acid was detected at later time points therefore a simultaneous zero-order formation mechanism was proposed.
Chidgey and Caldwell (1986), also investigated the influence of different dosing techniques by varying the dose size and the vehicle. This study too was reported to a high standard, and performed in line with good scientific principles, as such a reliability score of 2 was also assigned. Under the conditions of the test, the levels of metabolites in the plasma were found to be affected by dose size, test substance and time after dosing indicating the potential for the metabolic pathway to become saturated with high doses. In urine the proportion of administered 14C converted to hippuric, benzoic and benzylmercapturic acids were not significantly influenced by the size of the dose. The dose vehicle had no effect upon the metabolic pattern of benzyl acetate. Excretion of the test substance was found to be rapid, and was considered complete by 72 hours less than 1 % was found to be retained by the carcass after 72 hours.
NTP (1986), also investigated whether the size, route and number of doses benzyl acetate affected the rate of absorption and metabolism in rats and mice. Rats were dosed singly either orally, intravenously or dermally and repeatedly via oral gavage. Mice were dosed singly either orally or intravenously and repeatedly via oral gavage. The study was reported to a good level in two publications and was performed in line with good scientific principles with only minor deficiencies affect the quality of the data presented. In line with the principles for assessing data quality, in accordance with Klimisch (1997), the study was assigned a reliability score of 2. Under the conditions of the test, absorption of benzyl acetate was found to be rapid and almost complete via the gastro-intestinal tract (considerably slower via dermal absorption) and metabolism was also found to be rapid and complete, with almost the entirety of the radioactive dose recovered in urine as the major metabolite hippuric acid. No radioactivity was observed in any of the tissues analysed after 24 hours post-dosing. No radioactivity was found to be retained in the tissues, and the level of recovery of the test substance in the urine indicated that benzyl acetate will not accumulate in the body.
Dermal absorption
The key study, Garnett et al (1994), performed a comparison of the rate of absorption of the test substance benzyl acetate in both rat and human skin in vitro using diffusion cells. Absorption was measured up to 72 hours in both tissues and compared. The method was comparable to the OECD guideline 428, however extra evaluations were performed comparing inter-species differences. The study was well reported and performed in line with good scientific principles. The study was therefore assigned a reliability score 2 in accordance with Klimisch (1997). The study was performed on the substance benzyl acetate, which is structurally similar to 1-phenylethyl acetate (the only difference being, a methyl group present on the carbon chain of 1-phenylethyl acetate) and considered to be representative of the effects. Under the conditions of the test, low level absorption of the test substance, benzyl acetate through human skin was demonstrated (17.8 ± 3.3 %) indicating that some low level systemic exposure may occur in humans. The study did demonstrate that human skin in less permeable than rat skin, with the absorption through rat skin reaching 55.8 ± 5.0 %.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.